RAGE-mediated interstitial fibrosis in neonatal obstructive nephropathy is independent of NF-κB activation

Kidney International

Volumn 84, Issue 5, 2013, Pages 911-919

  Gasparitsch, Mojca ^a   Arndt, Anne Karin ^b   Pawlitschek, Felix ^c   Oberle, Stephan ^d   Keller, Ursula ^a   Kasper, Michael ^e   Bierhaus, Angelika ^d   Schaefer, Franz ^d   Weber, Lutz T ^a   Lange Sperandio, Bärbel ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

ICAM 1; NF kB; RAGE; renal fibrosis; unilateral ureteral obstruction

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GALECTIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; G2 PHASE CELL CYCLE CHECKPOINT; KIDNEY FIBROSIS; KIDNEY STRUCTURE; LEUKOCYTE COUNT; MOLECULAR PATHOLOGY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; URETER OBSTRUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CADHERINS; CELL PROLIFERATION; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; G2 PHASE CELL CYCLE CHECKPOINTS; GALECTIN 3; GENOTYPE; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; KIDNEY DISEASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PHENOTYPE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; URETERAL OBSTRUCTION;

EID: 84888318828     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.171     Document Type: Article

References (43)

1. Truong LD, Gaber L, Eknoyan G. Obstructive uropathy. Contrib Nephrol 2011; 169: 311-326.
2. Klein J, Gonzalez J, Miravete M et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol 2010; 92: 168-192.
3. Chevalier RL, Thornhill BA, Forbes MS et al. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 2010; 25: 687-697.
4. Lange-Sperandio B, Trautmann A, Eickelberg O et al. Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice. Am J Pathol 2007; 171: 861-871.
5. Lange-Sperandio B, Schimpgen K, Rodenbeck B et al. Distinct roles of Mac-1 and its counter-receptors in neonatal obstructive nephropathy. Kidney Int 2006; 69: 81-88.
6. Lange-Sperandio B, Sperandio M, Nawroth P et al. RAGE signaling in cell adhesion and inflammation. Curr Ped Rev 2007; 3: 1-9.
7. Han SH, Kim YH, Mook-Jung I. RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 2011; 31: 91-97.
8. Busch M, Franke S, Ruster C et al. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010; 40: 742-755.
9. Bierhaus A, Stern DM, Nawroth PP. RAGE in inflammation: a new therapeutic target Curr Opin Investig Drugs 2006; 7: 985-991.
10. Frommhold D, Kamphues A, Mannigel I et al. RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 2010; 116: 841-849.
11. Bierhaus A, Nawroth PP. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009; 52: 2251-2263.
12. Chavakis T, Bierhaus A, Al Fakhri N et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003; 198: 1507-1515.
13. Frommhold D, Kamphues A, Dannenberg S et al. RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner. BMC Immunol 2011; 12: 56.
14. Soro-Paavonen A, Watson AM, Li J et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008; 57: 2461-2469.
15. Liliensiek B, Weigand MA, Bierhaus A et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 2004; 113: 1641-1650.
16. Bopp C, Bierhaus A, Hofer S et al. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 2008; 12: 201.
17. Sadik NA, Mohamed WA, Ahmed MI. The association of receptor of advanced glycated end products and inflammatory mediators contributes to endothelial dysfunction in a prospective study of acute kidney injury patients with sepsis. Mol Cell Biochem 2011; 359: 73-81.
18. Morris-Rosenfeld S, Blessing E, Preusch MR et al. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Eur J Clin Invest 2011; 41: 1164-1171.
19. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009; 75: 1145-1152.
20. Yang L, Besschetnova TY, Brooks CR et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543.
21. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011; 80: 915-925.
22. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011; 12: 1035-1044.
23. Vielhauer V, Kulkarni O, Reichel CA et al. Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol 2010; 30: 318-333.
24. Henderson NC, MacKinnon AC, Farnworth SL et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008; 172: 288-298.
25. Tsoporis JN, Izhar S, Leong-Poi H et al. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptormediated mechanism for myocyte apoptosis postinfarction. Circ Res 2010; 106: 93-101.
26. Jin Q, Chen H, Luo A et al. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One 2011; 6: e19375.
27. Kang R, Tang D, Schapiro NE et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010; 17: 666-676.
28. Kang R, Tang D, Loze MT et al. Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE). Autophagy 2011; 7: 91-93.
29. Kawabata H, Setoguchi T, Yone K et al. High mobility group box 1 is upregulated after spinal cord injury and is associated with neuronal cell apoptosis. Spine 2010; 35: 1109-1115.
30. Stolzing A, Sellers D, Llewelyn O et al. Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 2010; 191: 453-465.
31. Friggeri A, Banerjee S, Biswas S et al. Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol 2011; 186: 6191-6198.
32. He M, Kubo H, Morimoto K et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep 2011; 12: 358-364.
33. Leemans JC, Butter LM, Pulskens WP et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009; 4: e5704.
34. Hu MC, Wang Y, Qiu WR et al. Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IkappaB kinases (IKK-alpha/beta) and IKK-beta is a developmentally regulated protein kinase. Oncogene 1999; 18: 5514-5524.
35. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
36. Palanisamy N, Kannappan S, Anuradha CV. Genistein modulates NF-kappaB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur J Pharmacol 2011; 667: 355-364.
37. Tang SC, Leung JC, Lai KN. The kallikrein-kinin system. Contrib Nephrol 2011; 170: 145-155.
38. Park EY, Seo MJ, Park JH. Effects of specific genes activating RAGE on polycystic kidney disease. Am J Nephrol 2010; 32: 169-178.
39. Guimaraes EL, Empsen C, Geerts A et al. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol 2010; 52: 389-397.
40. Englert JM, Hanford LE, Kaminski N et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172: 583-591.
41. Buckley ST, Ehrhardt C. The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol 2010; 2010: 917108.
42. Inghilleri S, Morbini P, Campo I et al. Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. Pulm Med 2011; 2011: 421409.
43. Bierhaus A, Schiekofer S, Schwaninger M et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001; 50: 2792-2808.